Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas aeruginosa ...

The Pseudomonas Aeruginosa Infection Treatment Market addresses the management of infections caused by the opportunistic pathogen Pseudomonas aeruginosa. This bacterium poses a significant threat, ...

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. As the healthcare ...

The bacterium Pseudomonas aeruginosa is resistant to all antibiotics on the market. Therefore, there is a great need for new therapeutic approaches. In order to find them, it helps to understand how ...

Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...

Dear Doctors: I recently had a surgical procedure and was in the hospital for a few days. While I was there, I was diagnosed with pseudomonas. Can you please explain what that is? How do you get it? I ...

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental ...

Lung infection is the cause of much of the morbidity and mortality associated with cystic fibrosis. Pseudomonas aeruginosa is the most frequent cause of lung infection in people with cystic fibrosis.